Revenue
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Can-Fite BioPharma Ltd. (CANF)
Price—Loading quote
Net income
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $405,000 | $674,000 | $743,000 | $810,000 | $853,000 | $763,000 | $2.0M | $3.8M | $789,000 | $165,000 | — |
| Research & development | $6.7M | $5.8M | $6.0M | $137,000 | $200,000 | $159,000 | $138,000 | $123,000 | $5.1M | $6.1M | — |
| Operating expenses | $10.4M | $8.8M | $8.9M | $10.9M | — | — | — | — | — | — | — |
| Operating income | −$9.9M | −$8.1M | −$8.2M | −$10.1M | −$12.8M | −$14.1M | −$12.0M | −$5.4M | −$7.2M | −$8.7M | — |
| Operating margin | −2,456.79% | −1,206.23% | −1,102.96% | −1,246.42% | −1,505.51% | −1,853.08% | −590.90% | −141.73% | −910.65% | −5,262.42% | — |
| EBITDA | −$9.9M | −$8.1M | −$8.2M | −$10.1M | −$12.8M | −$14.1M | −$12.0M | −$5.4M | −$7.2M | −$8.7M | — |
| EBITDA margin | −2,450.86% | −1,205.19% | −1,100.94% | −1,244.69% | −1,503.87% | −1,851.51% | −590.21% | −141.36% | −910.27% | −5,260.00% | — |
| Net income | −$9.8M | −$7.9M | −$7.6M | −$10.2M | −$12.6M | −$14.4M | −$12.6M | −$6.6M | −$6.4M | −$8.4M | — |
| Net profit margin | −2,426.67% | −1,169.14% | −1,027.46% | −1,255.93% | −1,478.90% | −1,892.92% | −621.31% | −172.02% | −815.34% | −5,086.67% | — |
| Basic EPSper basic share | -$5.97 | -$10.86 | -$0.01 | -$0.01 | -$0.03 | -$0.04 | -$0.14 | -$0.17 | -$0.19 | $0.30 | — |
| Diluted EPSper diluted share | -$5.97 | -$10.86 | -$0.01 | -$0.01 | -$0.03 | -$0.04 | -$0.14 | -$0.17 | -$0.19 | $0.30 | — |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
CITADEL ADVISORS LLC | 32.53K |
RHUMBLINE ADVISERS | 17.43K |
FIFTH THIRD BANCORP | 150 |
Fishman Pnina | 88 |
WELLS FARGO & COMPANY/MN | 59 |
Activest Wealth Management | 10 |
Regev Guy | 8 |
Avion Wealth | 5 |
MORGAN STANLEY | 1 |
TD Waterhouse Canada Inc. | 1 |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data